NCT04331275View on ClinicalTrials.gov

Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 18, 2020

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Solid Organ TransplantViral Infection
Interventions
BIOLOGICAL

Viral Specific T-cells (VSTs)

VSTs will be infused into solid organ transplant recipients who have evidence of viral infection.

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Hoxworth Blood Center

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER